Catalyst Pharmaceuticals (CPRX) Retained Earnings (2010 - 2026)
Catalyst Pharmaceuticals (CPRX) reported Retained Earnings of $523.3 million for Q1 2026, up 3078623.53% on a YoY basis from N/an in Q1 2025, and up 10.37% quarter-over-quarter from $474.2 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) Retained Earnings (2010 - 2026) Analysis & Trends
Catalyst Pharmaceuticals has reported Retained Earnings for 17 years, with the latest figure at $523.3 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 3078623.53% year-over-year to $523.3 million; the trailing twelve-month figure through Mar 2026 stood at $523.3 million (up 3078623.53% YoY), and the FY2025 full-year result was $474.2 million, up 740818.75% from the prior year.
- Retained Earnings for Q1 2026 stood at $523.3 million, up from $474.2 million in the prior quarter.
- The five-year high for Retained Earnings was $523.3 million in Q1 2026, with the low at -$453000.0 in Q1 2022.
- Historically, Retained Earnings has averaged $103.1 million across 5 years, with a median of $21500.0 in 2022.
- Annual changes were most pronounced in 2022 — Retained Earnings slumped 906.67% — and 2026, when it soared 3078623.53%.
- Catalyst Pharmaceuticals' Retained Earnings stood at $24000.0 in 2022, then sank by 41.67% to $14000.0 in 2023, then soared by 357.14% to $64000.0 in 2024, then surged by 740818.75% to $474.2 million in 2025, then rose by 10.37% to $523.3 million in 2026.
- The last three Retained Earnings figures came in at $523.3 million (Q1 2026), $474.2 million (Q4 2025), and $446.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Catalyst Pharmaceuticals | 3.84 Bn | 3.08 Bn | 134.92 Mn | 523.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 523.35 Mn |
| Dec 31, 2025 | 474.19 Mn |
| Sep 30, 2025 | 446.79 Mn |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | -17,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | 15,000.00 |
| Jun 30, 2023 | 19,000.00 |
| Mar 31, 2023 | 11,000.00 |
| Dec 31, 2022 | 24,000.00 |
| Sep 30, 2022 | 32,000.00 |
| Jun 30, 2022 | -130,000.00 |
| Mar 31, 2022 | -453,000.00 |
| Dec 31, 2021 | -148,000.00 |
| Sep 30, 2021 | -63,000.00 |
| Jun 30, 2021 | -37,000.00 |
| Mar 31, 2021 | -45,000.00 |
| Dec 31, 2020 | 31,000.00 |
| Sep 30, 2020 | -65.14 Mn |